Action Potential Duration Heterogeneity

Action Potential Duration Heterogeneity refers to the physiological and electrophysiological variation in the length of the cardiac action potential (AP) across different regions of the myocardium. This heterogeneity reflects differences in the timing of repolarization among cardiac cells, leading to spatial and temporal dispersion in electrical recovery. It is a fundamental property of cardiac tissue that influences normal heart rhythm and plays a critical role in the development of arrhythmias.

Basis of Action Potential Duration Heterogeneity

Action potential duration (APD) is defined as the time interval between the initial upstroke (depolarization) of the cardiac action potential and its return to the resting membrane potential (repolarization). Variations in APD arise from intrinsic cellular differences in ionic channel expression and function, as well as from extrinsic factors such as neurohormonal influences and interactions with the extracellular matrix.

Key determinants of APD heterogeneity include:

• Differences in ion channel densities and kinetics, particularly potassium currents (e.g., I_to, I_Kr, I_Ks, I_K1), calcium currents (I_Ca,L), and sodium currents (I_Na).
• Variability in calcium handling and intracellular signaling pathways.
• Structural and functional heterogeneity among myocardial layers (endocardium, midmyocardium or M cells, and epicardium).
• Regional differences in autonomic innervation and metabolic state.

Spatial Distribution of APD Heterogeneity

APD heterogeneity exists both transmurally (across the ventricular wall) and along the longitudinal and circumferential axes of the heart.

Transmural Heterogeneity

The ventricular wall comprises layers with distinct electrophysiological properties:

• Epicardial cells typically display shorter APDs due to a prominent transient outward potassium current (I_to), which causes a rapid phase 1 notch in the action potential.
• M cells (midmyocardial cells) exhibit longer APDs, partly because of smaller I_Ks and larger late sodium current (I_Na,L), making them more susceptible to prolongation of repolarization.
• Endocardial cells have intermediate APDs but contribute to overall heterogeneity through unique ionic current profiles.

This transmural gradient is critical for the normal sequence of repolarization, which proceeds from epicardium to endocardium, enabling efficient ventricular contraction and relaxation.

Regional and Apex-Base Differences

APD heterogeneity is also observed from base to apex and between different ventricular regions. For example, apical myocytes may have different APDs compared to basal cells due to variations in ion channel expression, affecting the propagation of electrical signals and mechanical contraction.

Functional Implications of APD Heterogeneity

APD heterogeneity serves important physiological roles but can also predispose to arrhythmogenesis.

Normal Physiology

• It ensures orderly repolarization and refractory periods that optimize the timing of contraction and relaxation.
• The dispersion of repolarization contributes to the T wave morphology on the electrocardiogram (ECG).

Arrhythmogenesis

• Excessive heterogeneity increases dispersion of refractoriness, creating vulnerable substrates for reentrant circuits.
• It facilitates afterdepolarizations and triggered activity in vulnerable regions, particularly in M cells.
• Pharmacological agents or pathological conditions that exaggerate APD differences can lead to ventricular arrhythmias, such as Torsades de Pointes.

Measurement and Quantification of APD Heterogeneity

Assessment of APD heterogeneity can be conducted through:

• Intracellular recordings using microelectrodes in isolated cardiac tissue preparations.
• Optical mapping with voltage-sensitive dyes to visualize spatial distribution of APD.
• Electrocardiographic markers, such as QT interval dispersion.
• Mathematical modeling to simulate ionic currents and predict heterogeneity effects.

Quantitative metrics include differences in APD between regions (e.g., epicardium vs. endocardium), standard deviation of APD across multiple sites, and indices of dispersion of repolarization.

Molecular and Ionic Mechanisms Underlying APD Heterogeneity

The heterogeneity results primarily from differences in ion channel expression and function:

• Potassium currents: Variations in transient outward (I_to), rapid delayed rectifier (I_Kr), and slow delayed rectifier (I_Ks) currents modulate repolarization speed.
• Calcium currents: The L-type calcium current (I_Ca,L) affects plateau phase duration.
• Sodium currents: Late sodium current (I_Na,L) prolongs APD in certain myocardial layers.
• Calcium handling proteins: Differences in sarcoplasmic reticulum Ca²⁺ release and uptake influence membrane potential indirectly.

Gene expression differences and post-translational modifications further regulate these ionic currents, contributing to heterogeneity.

Pathological Modulation of APD Heterogeneity

Various disease states alter APD heterogeneity, often increasing arrhythmia risk:

• Ischemia and infarction cause regional conduction slowing and APD changes.
• Heart failure remodels ion channel expression, increasing dispersion.
• Genetic channelopathies (e.g., Long QT syndrome) exaggerate APD differences.
• Drug effects can disproportionately affect certain myocardial layers, altering heterogeneity.

Understanding these changes is essential for risk stratification and therapeutic interventions.

Therapeutic Relevance and Targeting APD Heterogeneity

Modulating APD heterogeneity presents a strategy to prevent or treat arrhythmias:

• Antiarrhythmic drugs may homogenize repolarization or selectively target regions with abnormal APDs.
• Pacing therapies can alter activation sequences to reduce dispersion.
• Gene therapy and molecular modulators aim to normalize ion channel function and reduce heterogeneity.

Therapeutic approaches must balance reducing arrhythmogenic dispersion without impairing normal cardiac function.

Summary of Concepts

Action Potential Duration Heterogeneity is a complex, multi-level phenomenon integral to cardiac electrophysiology. It arises from cellular and molecular diversity within the myocardium, resulting in spatial differences in repolarization timing. While essential for normal cardiac function, excessive or pathological heterogeneity increases susceptibility to life-threatening arrhythmias, making it a critical focus for research and clinical management in cardiac electrophysiology.